Valiant Laboratories Ltd. Share Price

Overview

Valiant Laboratories Ltd. share price is currently ₹121.06, up by ₹5.21 (4.5%) from its previous closing price of ₹115.85. The share price has declined -1.1% over the past month and gained 49.88% over the past year. The stock's 52-week low and high are ₹48.12 and ₹131.13, respectively. Valiant Laboratories Ltd. has a market capitalisation of ₹ 650.66 Cr. The share price was last updated on 13 Oct 2026, 11:00 AM IST.

Valiant Laboratories Ltd.

VALIANTLAB

₹0.00

₹5.21

4.50%

Healthcare

₹0.00(%)1D

Updated: 13 Oct 2026, 11:00:34 am IST

Market Data

Open Price

₹121.07

Prev. Close

₹115.85

₹118.17

Day Low

₹122.59

Day High

₹48.12

52 Week Low

₹131.13

52 Week High

HealthcarePharmaceuticals & Drugs

CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

41.04

Sector PE

42.62

PB Ratio

2.24

Sector PB

5.63

EPS

2.95

Dividend Yield

0.00

Today's Volume

19.626 K

5 Day Avg. Volume

44.773 K

PEG Ratio

-0.05

Market Cap.

₹ 650.66 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
Rights issue1 shares for every 4 shares held, at offer price of ₹75	18-Jul-2025	19-Jul-2025

Mutual Fund Ownership

Mutual Fund Ownership will be available shortly.

About Valiant Laboratories Ltd. 👋

Valiant Laboratories Limited is an India-based pharmaceutical ingredient manufacturing company. The Company is focused on manufacturing a Paracetamol active pharmaceutical ingredient (API)/bulk drug. It has several applications in the treatment of conditions such as headache, muscle ache, arthritis, backache, toothache, cold and fever. It is also used in the management of severe pain such as post-surgical and cancer pain. It operates a single-location manufacturing facility on the Tarapur industrial estate.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →

Akshay Patel

16 May • 2:22 PM · SEBI-Registered Analyst

VALIANTLAB

published its audited financial results for FY26 in newspapers on May 16, 2026. The company reported a standalone net profit of ₹554.82 lakhs, a turnaround from the previous year's loss, with revenue increasing to ₹21,704.25 lakhs. However, consolidated results, which include subsidiary Valiant Advanced Sciences Private Limited, reflected a net loss of ₹326.79 lakhs for the year on revenue of ₹23,746.75 lakhs. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.

Mayank Kumar

11 Jul • 2:37 PM · SEBI-Registered Analyst

Valiant Lab

#Valiantlab Valiant Lab is moving out from the support with a good volume, trying to cross 100 EMA, A good upside is possible in this stock, keep it on your watchlist.